Latest business news
US stocks fell on Thursday on concerns of economic slowdown on the back of the US tariff war and ahead of Friday’s jobs data. At 10:20 AM ET, the Dow Jones Industrial Average fell 126.69 points, or 0.30%, to 42,301.05, the S&P 500 lost 12.71 points, or 0.21%, to 5,958.10 and the Nasdaq Composite lost…
Metal stocks witnessed some selling pressure in trade on Friday, May 29, with the Nifty Metal pack emerging as the worst sectoral performer. Concerns around tariffs imposed by US President Donald Trump and the trade deal with China kept the sentiment subdued. US Treasury Secretary Scott Bessent said trade talks with China were “a bit…
Gold price outlook: Gold Futures on India’s Multi Commodity Exchange (MCX) closed 0.02 per cent or ₹21 lower on Friday, 23 May 2025, after a rally fueled by the renewed trade tensions in the global economy over US President Donald Trump’s stance with the European Union tariffs. Gold Futures for the June 2025 contract closed…
MUMBAI (Reuters) -The Indian rupee is likely to open higher on Thursday, supported by the strength in Asian peers, with investors shying away from the dollar due to U.S. fiscal concerns. The 1-month non-deliverable forward indicated a open in the 85.55 to 85.58 range, versus 85.6375 in the previous session. The offshore Chinese yuan rose…
NEW YORK – Oil prices fell about 2% to a two-week low on Tuesday as investors braced for OPEC to boost output and worried U.S. President Donald Trump’s tariffs would hit the global economy and slow demand for the fuel. Brent crude futures fell by $1.61, or 2.4%, to settle at $64.25 per barrel. U.S….
Cautious optimism markets may stabilize after sharp volatility But trade deal hopes may not last long Perceived Fed’s flexibility on rate cuts helps push yields lower Yield curve ‘bull-flattens’ on cloudy economic outlook (Adds analyst comments, economic data, graphic; updates market levels) NEW YORK, April 25 (Reuters) – U.S. Treasury yields declined on Friday amid…
However, experts have cautioned about potential risks related to liquidity, taxation, and regulatory compliance. In a consultation paper released on 17 April, Sebi proposed increasing the single issuer investment limit for equity schemes from 5% to 10% of net asset value (NAV) and raising the overall investment limit in REITs and InvITs for equity and…
Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump’s tariffs are looming on the horizon? “One product approval by itself doesn’t suddenly make a company more attractive,” said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. “Earlier-than-expected approval for Abraxane is positive,…